Search
for

    Sort by

    Research 541–570 of 1000+

    1. Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer International Journal of Molecular Sciences · 2025 · 1 citations
    2. Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays Phytotherapy Research · 2016 · 3 citations
    3. Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment 2018 · 1 citations
    4. Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men Cancer Epidemiology and Prevention Biomarkers · 2007
    5. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    6. Finasteride en el año 2006 Revista Argentina de Urología · 2006
    7. Is Dihydrotestosterone a Classic Hormone? Endocrine Reviews · 2017 · 4 citations
    8. PAK4 signaling in health and disease: defining the PAK4–CREB axis Experimental & Molecular Medicine · 2019 · 81 citations
    9. Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase Asian journal of Current Research in Clinical Cancer · 2022
    10. 5α-Reductase inhibitors in androgenetic alopecia Current Opinion in Endocrinology, Diabetes and Obesity · 2014 · 29 citations
    11. Should Finasteride Be Routinely Given Preoperatively for TURP? ISRN Urology (Print) · 2013 · 2 citations
    12. Sulfatase inhibitors: a patent review Expert Opinion on Therapeutic Patents · 2012 · 47 citations
    13. Testosterone therapy in men: Clinical and pharmacological perspectives Journal of Endocrinological Investigation · 2000 · 25 citations
    14. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    15. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    16. 5α-Reductase Inhibitors (5ARIs) and Male Reproduction Advances in Experimental Medicine and Biology · 2017 · 15 citations
    17. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient Journal of the European Academy of Dermatology and Venereology · 2018 · 9 citations
    18. The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study The Aging Male · 2020 · 6 citations
    19. Exploring obesity-related endocrine disorders beyond diabetes: a narrative review The Egyptian Journal of Internal Medicine · 2024 · 4 citations
    20. Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions Frontiers in Pharmacology · 2023 · 3 citations
    21. African Journal of Biomedical Research 2025
    22. EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA Journal of Men s Health · 2020
    23. Crystal Structure and Synthesis of 17α-Acetoxy-4-bromopregn-4-ene-3,20-dione Analytical Sciences · 2002
    24. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    25. Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers Biomedicines · 2022 · 57 citations
    26. Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis Frontiers in Oncology · 2022 · 11 citations
    27. Clinical Development of Topoisomerase-Interactive Drugs Advances in pharmacology · 1994 · 10 citations
    28. Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis Frontiers in Endocrinology · 2022 · 5 citations
    29. Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties Discover Oncology · 2026
    30. Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team International Journal of Clinical Oncology · 2026